Patents by Inventor Brian DeDecker

Brian DeDecker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250059546
    Abstract: Systems, methods and compositions for the inducible production of squalene in plants seeds, in part by downregulating the endogenous sterol production pathway, for example through heterologous expression of one or more inhibitory RNA molecules, and in a preferred embodiment a novel hairpin multiple RNAi molecules that target paralogs of squalene epoxidase (SQE). Downregulating SQE causes a buildup of squalene by both blocking downstream conversion of squalene into sterols and releasing the negative feedback loop that sterols have with the upstream MVA pathway.
    Type: Application
    Filed: October 24, 2024
    Publication date: February 20, 2025
    Inventors: Brian DEDECKER, Simon KALMUS, David BIRKHAEUSER, Nickles BADGER
  • Publication number: 20250042965
    Abstract: The present invention includes novel systems, methods, and compositions for the non-endogenous production of human Osteopontin in plants, and preferably Glycine max or other high-biomass crops.
    Type: Application
    Filed: October 24, 2024
    Publication date: February 6, 2025
    Inventors: Brian DEDECKER, Simon KALMUS
  • Publication number: 20220162687
    Abstract: The current inventive technology includes systems, methods, and compositions for directly synthesizing sticky ended DNA fragments for subsequent gene assembly. In a preferred embodiment, the inventive technology includes strategies for the direct synthesis of sticky ended DNA with 5? overhangs that have any desired length and base composition, using typical PCR protocols with no additional manipulation. In another embodiment, the inventive technology includes the direct synthesis of sticky ended DNA using chemically modified oligonucleotide primers in a polymerase chain reaction (PCR). In certain embodiments, the inventive technology allows for the generation of larger DNA constructs formed by the sticky-ended assemblies generally described herein compared to traditional synthesis and ligation applications.
    Type: Application
    Filed: June 8, 2020
    Publication date: May 26, 2022
    Inventors: Brian DEDECKER, Madison L. ADAMTHWAITE, Nathaniel Z. MOORE, Lauren A. VANHAUSEN, Mckayla T. VLASITY
  • Publication number: 20080044405
    Abstract: Certain noble metal complexes are able to strip peptides from class II MHC proteins, resulting in class II MHC peptides in a peptide-empty conformation that do not support T-cell activation. Methods for identifying additional compounds are provided. Also provided are methods for use of this class of compounds to inhibit an immune response and to treat subjects having an unwanted immune response such as autoimmunity, allograft rejection, allergy, asthma, and inflammation.
    Type: Application
    Filed: February 23, 2007
    Publication date: February 21, 2008
    Applicant: President and Fellows of Harvard College
    Inventors: Brian DeDecker, Stephen De Wall